Results for tag: "Doptelet"

Doptelet (avatrombopag) is a drug used to treat thrombocytopenia, a condition characterized by a low platelet count, in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. It is also used to treat thrombocytopenia in adults with chronic kidney disease who are on dialysis and scheduled to undergo a procedure. Doptelet works by stimulating the production of platelets in the bone marrow, which helps to reduce the risk of bleeding during a procedure. The Doptelet market is composed of pharmaceutical companies that manufacture and distribute the drug. These companies are involved in the research and development of new drugs, as well as the marketing and sales of existing drugs. Companies in the Doptelet market include Daiichi Sankyo, Inc., AstraZeneca, and Takeda Pharmaceuticals. Show Less Read more